<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0872-0754</journal-id>
<journal-title><![CDATA[Nascer e Crescer]]></journal-title>
<abbrev-journal-title><![CDATA[Nascer e Crescer]]></abbrev-journal-title>
<issn>0872-0754</issn>
<publisher>
<publisher-name><![CDATA[Centro Hospitalar do Porto]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0872-07542011000100005</article-id>
<title-group>
<article-title xml:lang="pt"><![CDATA[Hemoperfusão com carvão activado na intoxicação grave por carbamazepina]]></article-title>
<article-title xml:lang="en"><![CDATA[Efficacy of hemoperfusion with activated charcoal in the treatment of severe poisoning by carbamazepine]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cálix]]></surname>
<given-names><![CDATA[Maria José]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Gonçalves]]></surname>
<given-names><![CDATA[Márcia]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Castro]]></surname>
<given-names><![CDATA[José Manuel]]></given-names>
</name>
<xref ref-type="aff" rid="A02"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ventura]]></surname>
<given-names><![CDATA[Ana]]></given-names>
</name>
<xref ref-type="aff" rid="A03"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Real]]></surname>
<given-names><![CDATA[Marta Vila]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Vilarinho]]></surname>
<given-names><![CDATA[António]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Centro Hospitalar Vila Nova de Gaia/Espinho Serviço de Pediatria ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<aff id="A02">
<institution><![CDATA[,Centro Hospitalar Vila Nova de Gaia/Espinho Serviço de Neurologia ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<aff id="A03">
<institution><![CDATA[,Centro Hospitalar Vila Nova de Gaia/Espinho Serviço de Nefrologia ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>03</month>
<year>2011</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>03</month>
<year>2011</year>
</pub-date>
<volume>20</volume>
<numero>1</numero>
<fpage>23</fpage>
<lpage>25</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_arttext&amp;pid=S0872-07542011000100005&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_abstract&amp;pid=S0872-07542011000100005&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_pdf&amp;pid=S0872-07542011000100005&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Caso clínico: Os autores apresentam o caso de uma adolescente admitida no Serviço de Urgência por alterações neurológicas de início agudo e progressivas, existindo na residência um familiar medicado com um antiepiléptico. A avaliação inicial revelou sonolência, discurso adequado, disartria, nistagmo, dismetria bilateral e ataxia da marcha. Foi efectuado doseamento sérico de carbamazepina, que revelou valores muito elevados, confirmando intoxicação aguda por este fármaco. Não houve resposta à administração com carvão activado por via gastrointestinal, havendo mesmo agravamento do estado de consciência. Por esta razão, iniciou hemoperfusão com carvão activado, com recuperação completa do quadro neurológico ao m de três horas de tratamento. Conclusão: Os autores sublinham as dificuldades na abordagem de intoxicações graves provocadas por fármacos com forte ligação às proteínas, realçando a eficácia da hemoperfusão com carvão activado.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Case report: The authors present a case of a teenage girl admitted to the emergency room with a sudden progressive neurologic disorder. A family member was on antiepileptic drug treatment. The initial assessment revealed a drowsy adolescent with appropriate speech, though dysarthric, presenting nystagmus and bilateral dysmetria and gait ataxia. Serum assay was performed and revealed high levels of carbamazepine thus confirming acute poisoning with this drug. Activated charcoal therapy was done with no response, even with deterioration of the level of consciousness. Hemoperfusion with activated charcoal was then performed with complete neurological recovery within three hours. Conclusion: The authors underline the difficulties in dealing with severe cases of poisoning caused by drugs with high protein binding and emphasize the effectiveness of hemoperfusion with activated charcoal.]]></p></abstract>
<kwd-group>
<kwd lng="pt"><![CDATA[Carbamazepina]]></kwd>
<kwd lng="pt"><![CDATA[intoxicação]]></kwd>
<kwd lng="pt"><![CDATA[sobredosagem]]></kwd>
<kwd lng="pt"><![CDATA[antiepilépticos]]></kwd>
<kwd lng="pt"><![CDATA[hemoperfusão]]></kwd>
<kwd lng="pt"><![CDATA[carvão activado]]></kwd>
<kwd lng="pt"><![CDATA[alteração do estado de consciência]]></kwd>
<kwd lng="en"><![CDATA[Carbamazepine]]></kwd>
<kwd lng="en"><![CDATA[poisoning]]></kwd>
<kwd lng="en"><![CDATA[overdose]]></kwd>
<kwd lng="en"><![CDATA[antiepileptic drugs]]></kwd>
<kwd lng="en"><![CDATA[hemoperfusion]]></kwd>
<kwd lng="en"><![CDATA[activated charcoal]]></kwd>
<kwd lng="en"><![CDATA[disturbed level of consciousness]]></kwd>
</kwd-group>
</article-meta>
</front><body><![CDATA[ <p><b>Hemoperfusão com carvão activado na intoxicação grave por carbamazepina </b></p>      <p>&nbsp;</p>     <p>Maria José Cálix<sup>1</sup>, Márcia Gonçalves<sup>1</sup>, José Manuel Castro<sup>2</sup>,  Ana Ventura<sup>3</sup>, Marta Vila Real<sup>1</sup>, António Vilarinho<sup>1</sup></p>      <p><sup>1 </sup>Serviço de Pediatria</p>      <p><sup>2 </sup>Serviço de Neurologia</p>      <p><sup>3 </sup>Serviço de Nefrologia – CH Vila Nova de Gaia / Espinho </p>     <p><a name="top0"></a><a href="#0">Correspond&ecirc;ncia</a></p>     <p>&nbsp;</p>      <p><b>RESUMO </b></p>     <p><b>Caso clínico: </b>  Os autores apresentam o caso de uma adolescente admitida no Serviço de Urgência  por alterações neurológicas de início agudo e progressivas, existindo na  residência um familiar medicado com um antiepiléptico. A avaliação inicial  revelou sonolência, discurso adequado, disartria, nistagmo, dismetria bilateral  e ataxia da marcha. </p>     ]]></body>
<body><![CDATA[<p>Foi efectuado doseamento sérico de carbamazepina, que revelou valores muito  elevados, confirmando intoxicação aguda por este fármaco. Não houve resposta à  administração com carvão activado por via gastrointestinal, havendo mesmo  agravamento do estado de consciência. Por esta razão, iniciou hemoperfusão com  carvão activado, com recuperação completa do quadro neurológico ao m de três  horas de tratamento. </p>     <p><b>Conclusão: </b> Os autores sublinham as dificuldades na abordagem de intoxicações graves  provocadas por fármacos com forte ligação às proteínas, realçando a eficácia da  hemoperfusão com carvão activado. </p>     <p><b>Palavras-chave:</b>  Carbamazepina, intoxicação, sobredosagem, antiepilépticos, hemoperfusão, carvão  activado, alteração do estado de consciência. </p>      <p>&nbsp;</p>      <p><b>Efficacy of hemoperfusion with activated charcoal in the treatment of severe  poisoning by carbamazepine </b></p>      <p><b>ABSTRACT </b></p>     <p><b>Case report: </b> The authors present a case of a teenage girl admitted to the emergency room with  a sudden progressive neurologic disorder. A family member was on antiepileptic  drug treatment. The initial assessment revealed a drowsy adolescent with  appropriate speech, though dysarthric, presenting nystagmus and bilateral  dysmetria and gait ataxia. </p>     <p>Serum assay was performed and revealed high levels of carbamazepine thus  confirming acute poisoning with this drug. Activated charcoal therapy was done  with no response, even with deterioration of the level of consciousness.  Hemoperfusion with activated charcoal was then performed with complete  neurological recovery within three hours. </p>     <p><b>Conclusion: </b> The authors underline the difficulties in dealing with severe cases of poisoning  caused by drugs with high protein binding and emphasize the effectiveness of  hemoperfusion with activated charcoal. </p>     <p><b>Keywords:</b>  Carbamazepine, poisoning, overdose, antiepileptic drugs, hemoperfusion,  activated charcoal, disturbed level of consciousness. </p>     ]]></body>
<body><![CDATA[<p>&nbsp;</p>     <p>Texto completo disponível apenas em PDF.</p>     <p>Full text only available in PDF format.</p>     <p>&nbsp;</p>     <p><b>BIBLIOGRAFIA </b></p>      <p>1. Waseem M, Gernsheimer JR. Carbamazepine toxicity. Disponível em: emedicine.medscape.com    2009. URL: <a href="http://emedicine.medscape.com/article/1011240" target="_blank">http://emedicine.medscape.com/article/1011240</a>    [23.05.2010] </p>      <p>2. Askenazi DJ, Goldstein SL, Chang I-F, Elenberg E, Feig DI. Management of a  severe carbamazepine overdose using albuminenhanced continuous venovenous  hemodialysis. Pediatrics 2004; 113:406-9. </p>      <p>3. Bronstein AC, Spyker DA, Cantilena JR LR, Green JL, Rumack BH, Stuart HE.  2007 Annual Report of the American Association of Poison Control Centers’  National Poison Data System (NPDS): 25th Annual Report. Clinical Toxicology 2008; 46:927-1057.</p>      <!-- ref --><p>4. Ferreira A, Borges A, Rangel R, Monsanto P, Dias MJ, Carvalho M. Avaliação  das intoxicações medicamentosas em Portugal. Revista da Faculdade de Ciências da  Saúde – Universidade Fernando Pessoa 2008; 5:94-110. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000031&pid=S0872-0754201100010000500001&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><p>5. Chan K-M, Aguanno JJ, Jansen R, Dletzler DN. Charcoal he­moperfusion for treatment of carbamazepine poisoning. Clin Chem 1981; 27:1300-2. </p>      ]]></body>
<body><![CDATA[<p>6. Fleischman A, Chiang VW. Carbamazepine overdose recognized by a tricyclic  antidepressant assay. Pediatrics 2001; 107:176-7. </p>      <p>7. Sanjurjo-Golpe E, Nogué-Xarau S. Intoxicaciones por fármacos  antiepilépticos. Jano 2006; 1592: 33-6. </p>      <p>8. Sethna M, Solomon G, Cedarbaum J, Kutt H. Successful treatment of massive  carbamazepine overdose. Epilepsia 1989;30:71-3. </p>      <p>9. Deshpande G, Meert KL, Valentini RP. Repeat charcoal hemoperfusion treatments in life threatening carbamazepine  overdose. Pediatr Nephrol 1999; 13:775-7. </p>      <!-- ref --><p>10. Fernandes ICOF, Terra CM, Fernandes JC, Martins FRP, Bousso A, Ejzenberg B,  et al. Intoxicação acidental por carbamazepina - Relato de um caso. Pediatria 1995; 17:155-8. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000037&pid=S0872-0754201100010000500002&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><p>11. Cameron RJ, Hungerford P, Dawson AH. Efficacy of charcoal hemoperfusion in  massive carbamazepine poisoning. J Toxicol Clin Toxicol 2002; 40:507-12. </p>      <p>&nbsp;</p>     <p><b><a href="#top0">CORRESPONDÊNCIA</a><a name="0"></a></b></p>      <p>Maria José Cálix </p>     <p><a href="mailto:mariajosecalix@gmail.com">mariajosecalix@gmail.com</a></p>      ]]></body>
<body><![CDATA[ ]]></body><back>
<ref-list>
<ref id="B1">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ferreira]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Borges]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Rangel]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Monsanto]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Dias]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Carvalho]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang="pt"><![CDATA[Avaliação das intoxicações medicamentosas em Portugal]]></article-title>
<source><![CDATA[Revista da Faculdade de Ciências da Saúde - Universidade Fernando Pessoa]]></source>
<year>2008</year>
<volume>5</volume>
<page-range>94-110</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fernandes]]></surname>
<given-names><![CDATA[ICOF]]></given-names>
</name>
<name>
<surname><![CDATA[Terra]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
<name>
<surname><![CDATA[Fernandes]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Martins]]></surname>
<given-names><![CDATA[FRP]]></given-names>
</name>
<name>
<surname><![CDATA[Bousso]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ejzenberg]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang="pt"><![CDATA[Intoxicação acidental por carbamazepina: Relato de um caso]]></article-title>
<source><![CDATA[Pediatria]]></source>
<year>1995</year>
<volume>17</volume>
<page-range>155-8</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
